
### [NCIT:C3764](http://purl.obolibrary.org/obo/NCIT_C3764)
**Label:** Adenomatous Polyp

**Subclasses:** [NCIT:C43602](http://purl.obolibrary.org/obo/NCIT_C43602) (Gallbladder Papillary Adenoma), [NCIT:C43603](http://purl.obolibrary.org/obo/NCIT_C43603) (Gallbladder Tubulopapillary Adenoma), [NCIT:C3339](http://purl.obolibrary.org/obo/NCIT_C3339) (Familial Adenomatous Polyposis), [NCIT:C4135](http://purl.obolibrary.org/obo/NCIT_C4135) (Multiple Adenomatous Polyps), [NCIT:C96478](http://purl.obolibrary.org/obo/NCIT_C96478) (Colorectal Adenomatous Polyp), [NCIT:C96479](http://purl.obolibrary.org/obo/NCIT_C96479) (Colon Adenomatous Polyp), [NCIT:C7720](http://purl.obolibrary.org/obo/NCIT_C7720) (Gallbladder Adenoma), [NCIT:C6728](http://purl.obolibrary.org/obo/NCIT_C6728) (Gardner Syndrome), [NCIT:C96480](http://purl.obolibrary.org/obo/NCIT_C96480) (Rectal Adenomatous Polyp), [NCIT:C43601](http://purl.obolibrary.org/obo/NCIT_C43601) (Gallbladder Tubular Adenoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 39.90%


